Source: Blood Cells, Molecules and Diseases. Unidades: FMRP, FCFRP
Subjects: LEUCEMIA MIELOIDE AGUDA, APOPTOSE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. F. et al. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, v. 53, n. 1-2, p. 47-55, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2014.02.008. Acesso em: 03 out. 2024.APA
Ferreira, A. F., Moura, L. G., Tojal, I., Ambrósio, L., Simões, B. P., Hamerschlak, N., et al. (2014). ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, 53( 1-2), 47-55. doi:10.1016/j.bcmd.2014.02.008NLM
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008Vancouver
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008